[HTML][HTML] Peptide-based vaccines and therapeutics for COVID-19

PV Bagwe, PV Bagwe, SS Ponugoti… - International Journal of …, 2022 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been prevalent in the
humans since 2019 and has given rise to a pandemic situation. With the discovery and …

[PDF][PDF] Peptide‑Based Vaccines and Therapeutics for COVID‑19

PV Bagwe, PV Bagwe, SS Ponugoti… - International Journal of …, 2022 - academia.edu
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been prevalent in the
humans since 2019 and has given rise to a pandemic situation. With the discovery and …

[HTML][HTML] Peptide-Based Vaccines and Therapeutics for COVID-19

PV Bagwe, PV Bagwe, SS Ponugoti… - International Journal of …, 2022 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been prevalent in the
humans since 2019 and has given rise to a pandemic situation. With the discovery and …

Peptide-based vaccines and therapeutics for COVID-19.

PV Bagwe, PV Bagwe, SS Ponugoti, SV Joshi - 2022 - cabidigitallibrary.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been prevalent in the
humans since 2019 and has given rise to a pandemic situation. With the discovery and …

Peptide-Based Vaccines and Therapeutics for COVID-19

PV Bagwe, PV Bagwe, SS Ponugoti… - International Journal of …, 2022 - search.proquest.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been prevalent in the
humans since 2019 and has given rise to a pandemic situation. With the discovery and …

Peptide-Based Vaccines and Therapeutics for COVID-19

PV Bagwe, PV Bagwe… - … journal of peptide …, 2022 - pubmed.ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been prevalent in the
humans since 2019 and has given rise to a pandemic situation. With the discovery and …

Peptide-Based Vaccines and Therapeutics for COVID-19.

PV Bagwe, PV Bagwe, SS Ponugoti… - … Journal of Peptide …, 2022 - search.ebscohost.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been prevalent in the
humans since 2019 and has given rise to a pandemic situation. With the discovery and …

Peptide-Based Vaccines and Therapeutics for COVID-19.

PV Bagwe, SS Ponugoti, SV Joshi - International Journal of Peptide …, 2022 - europepmc.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been prevalent in the
humans since 2019 and has given rise to a pandemic situation. With the discovery and …